The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

被引：0
|
作者：
C. J. Currie
C. D. Poole
E. A. M. Gale
机构：
[1] Cardiff University,School of Medicine
[2] The Pharma Research Centre,Department of Epidemiology
[3] Cardiff MediCentre,Diabetes and Metabolism, School of Medicine
[4] Pharmatelligence,undefined
[5] Bristol University,undefined
来源：
Diabetologia | 2009年 / 52卷
关键词：
Cancer; Insulin; Insulin analogues; Metformin; Sulfonylureas; Survival; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1766 / 1777
页数：11
相关论文
共 50 条
  • [1] The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
    Currie, C. J.
    Poole, C. D.
    Gale, E. A. M.
    DIABETOLOGIA, 2009, 52 (09) : 1766 - 1777
  • [2] The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese
    Hsieh, Ming-Chia
    Lee, Tzu-Chi
    Cheng, Shu-Min
    Tu, Shih-Te
    Yen, Ming-Hong
    Tseng, Chin-Hsiao
    EXPERIMENTAL DIABETES RESEARCH, 2012,
  • [3] The influence of glucose-lowering therapies on cancer specific mortality in type 2 diabetes
    Ioacara, S.
    Guja, C.
    Ionescu-Tirgoviste, C.
    Fica, S.
    Sabau, S.
    Radu, S.
    Anghel, M.
    Tiu, C.
    DIABETOLOGIA, 2011, 54 : S99 - S99
  • [4] Impact of glucose-lowering therapies on risk of stroke in type 2 diabetes
    Bonnet, F.
    Scheen, A. J.
    DIABETES & METABOLISM, 2017, 43 (04) : 299 - 313
  • [5] INFLUENCE OF GLUCOSE-LOWERING STRATEGIES ON FRACTURE RISK IN TYPE 2 DIABETES
    Gusova, A. A.
    Pavlova, M. G.
    Melnitchenko, G. A.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S160 - S161
  • [6] Glucose-lowering therapies in type 2 diabetes: Opportunities and challenges for peptides
    Bailey, Clifford J.
    PEPTIDES, 2018, 100 : 9 - 17
  • [7] Newer Glucose-Lowering Therapies in Older Adults with Type 2 Diabetes
    Bilal, Anika
    Pratley, Richard E.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (02) : 355 - 375
  • [8] Glucose-lowering therapies in patients with type 2 diabetes and cardiovascular diseases
    Prattichizzo, Francesco
    La Sala, Lucia
    Ryden, Lars
    Marx, Nikolaus
    Ferrini, Marc
    Valensi, Paul
    Ceriello, Antonio
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (2_SUPPL) : 73 - 80
  • [9] Frailty in randomised controlled trials of glucose-lowering therapies for type 2 diabetes
    Wightman, H.
    Butterly, E.
    Wei, L.
    Mcchrystal, R.
    Sattar, N.
    Adler, A.
    Phillipo, D.
    Dias, S.
    Welton, N.
    Clegg, A.
    Witham, M.
    Rockwood, K.
    Mcallister, D.
    Hanlon, P.
    AGE AND AGEING, 2025, 54
  • [10] Glucose-lowering medicines for type 2 diabetes
    Davoren, Peter
    AUSTRALIAN FAMILY PHYSICIAN, 2015, 44 (05) : 272 - 276
12345